Literature DB >> 8953317

Retrovirus-mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation.

M Lu1, N Zhang, M Maruyama, R G Hawley, A D Ho.   

Abstract

Cells of the hematopoetic system, especially hematopoietic progenitor and stem cells, are perceived as ideal targets for human gene therapy. In this report, the stability of retrovirus-mediated gene expression driven by three different potent promoters has been examined in purified human CD34+ cells. The promoters, murine stem cell virus (MSCV) long terminal repeat (LTR) and pgk, show gene expression in 10 times more hematopoietic colonies derived from CD34+ cells than the commonly used Moloney murine leukemia virus (Mo-MLV) LTR. Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) analysis, however, demonstrates that the levels of gene expression in retrovirus-transduced cells decrease with time in long-term bone marrow cultures and in suspension cultures containing hematopoietic growth factors. Removal of hematopoietic growth factors from the suspension culture medium was associated with a decrease in cell proliferation and differentiation, but with stable gene expression. Retrovirus-mediated gene expression is, therefore, inversely related to proliferation and differentiation of the transduced CD34+ cells. These observations may have implications in future design and implementation of human gene therapy protocols.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953317     DOI: 10.1089/hum.1996.7.18-2263

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  3 in total

1.  Transposon-mediated mutagenesis of somatic cells in the mouse for cancer gene identification.

Authors:  David A Largaespada
Journal:  Methods       Date:  2009-07-14       Impact factor: 3.608

Review 2.  Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.

Authors:  Perry B Hackett; David A Largaespada; Kirsten C Switzer; Laurence J N Cooper
Journal:  Transl Res       Date:  2013-01-10       Impact factor: 7.012

Review 3.  A transposon and transposase system for human application.

Authors:  Perry B Hackett; David A Largaespada; Laurence J N Cooper
Journal:  Mol Ther       Date:  2010-01-26       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.